STMN1P2

Across TCGA pan-cancer cohorts, STMN1P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated STMN1P2 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher STMN1P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated STMN1P2 expression acts as an unfavorable survival marker.

MESO, PAAD, and ACC are the cancer types where STMN1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.098	0.579	.001	108	view →
PAAD	OS	Tertile	All	0.094	0.640	<.001	36	view →
ACC	OS	Tertile	All	0.188	0.820	<.001	36	view →
UCEC	OS	Tertile	All	0.865	0.931	.001	36	view →
THYM	OS	Tertile	III,IV	0.212	0.953	.009	27	view →
CESC	DFS	Tertile	All	0.553	0.754	.012	18	view →
LUSC	OS	Tertile	III,IV	0.079	0.673	<.001	18	view →
SKCM	DFS	Tertile	IV	0.016	0.454	<.001	18	view →
LAML	DFS	Tertile	All	0.392	0.641	.021	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

STMN1P2–MESO (OS)

Open the MESO breakdown →